SUN PHARMACEUTICAL INDUSTRIES
Back to Income Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Profit After Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹11,565 Cr | ₹10,980 Cr | ₹9,648 Cr | ₹8,561 Cr | ₹3,406 Cr |
What is the latest Profit After Tax of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Profit After Tax |
|---|---|
| Mar2026 | ₹11,565 Cr |
| Mar2025 | ₹10,980 Cr |
| Mar2024 | ₹9,648 Cr |
| Mar2023 | ₹8,561 Cr |
| Mar2022 | ₹3,406 Cr |
How is Profit After Tax of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹11,565 Cr | 5.32 | |
| Mar2025 | ₹10,980 Cr | 13.80 | |
| Mar2024 | ₹9,648 Cr | 12.70 | |
| Mar2023 | ₹8,561 Cr | 151.36 | |
| Mar2022 | ₹3,406 Cr | - | |
Compare Profit After Tax of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,808.7 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| MANKIND PHARMA | ₹102,896.0 Cr | -0.7% | 5.4% | 0.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 0.5% |
6.2% |
17.3% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses